Market Trends in the use of Stem Cells for Cancer Therapeutics: From BMTs to Cord BloodTuesday, 22 January 2013 at 14:45 Add to Calendar ▼2013-01-22 11:15:002013-01-22 12:15:00Europe/LondonCTCs: Analysis of Market Trends and Clinical UtilitySELECTBIOenquiries@selectbiosciences.com Select Biosciences industry coverage of the stem cells field covers many market segments. In this presentation, we focus upon the use of various classes of stem cells for hematological and solid tumor therapies. Presented here are the use of bone marrow, peripheral blood, and cord blood and the associated market trends. Also, we present the current research efforts in the hematological cancer space plus an analysis of the clinical trials pipeline. Taken together, this presentation will provide a market assessment of the utility of stem cells in cancer therapeutics. |